You have 9 free searches left this month | for more free features.

De novo AML

Showing 1 - 25 of 7,205

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

Not yet recruiting
  • Acute Myeloid Leukemia in Children
  • Standard Intervention
  • Investigational Intervention
  • (no location specified)
Aug 8, 2023

Acute Myeloid Leukemia Trial in Baltimore, Houston (Atovaquone, Cytarabine, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
  • +1 more
Oct 7, 2022

Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    Sep 22, 2023

    AML Including AML de Novo and AML Secondary to MDS, DLBCL Trial (Birabresib Dose 20 mg)

    Terminated
    • AML Including AML de Novo and AML Secondary to MDS
    • DLBCL
    • Birabresib Dose 20 mg
    • (no location specified)
    Aug 23, 2022

    Newly-diagnosed APL (de Novo or Therapy-related), Relapsed APL Trial in Dresden (observational)

    Recruiting
    • Newly-diagnosed APL (de Novo or Therapy-related)
    • Relapsed APL
    • observational
    • Dresden, Germany
      Prof. Dr. U. Platzbecker
    Aug 10, 2022

    Acute Myeloid Leukemia Trial in France (Cytarabine and Idarubicin, CPX-315)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Amiens, France
    • +29 more
    Apr 8, 2022

    Entresto Versus ACEi/ARB in de Novo Heart Failure Patients

    Completed
    • de Novo Heart Failure
      • East Hanover, New Jersey
        Novartis
      Jul 19, 2023

      Early Detection of de Novo Cancer in Liver Transplant Recipients

      Completed
      • De Novo Cancer
      • Liver Transplant Disorder
        • (no location specified)
        Aug 5, 2022

        Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Mitoxantrone hydrochloride liposome injection
        • +3 more
        • (no location specified)
        May 29, 2023

        De Novo Metabolic Syndrome in Liver Transplant Patients After

        Completed
        • Single Transplant
        • 5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS
        • Rome, Italy
          Roberta Angelico
        Mar 29, 2023

        Hematological Malignancies - SANGUINE

        Recruiting
        • Hematologic Malignancy
        • Blood sampling for HemaChip screening/diagnostic testing
        • Bone marrow sampling
        • Olomouc, Czechia
        • +3 more
        Feb 9, 2023

        Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Mitoxantrone hydrochloride liposome injection
        • +3 more
        • Tianjin, China
          Institute of Hematology & Blood Diseases Hospital
        Jul 1, 2023

        Drug-coated Balloon, Drug-eluting Stent, De Novo Stenosis Trial in Beijing (Drug-coated balloon (Bingo© [Paclitaxel-coated

        Recruiting
        • Drug-coated Balloon
        • +2 more
        • Drug-coated balloon (Bingo© [Paclitaxel-coated Balloon], Yinyi Ltd., China)
        • Drug-eluting stent
        • Beijing, China
          Fuwai Hospital, National Center for Cardiovascular Diseases,Chin
        Oct 14, 2023

        Acute Myeloid Leukemia Trial in Taipei

        Enrolling by invitation
        • Acute Myeloid Leukemia
          • Taipei, Taiwan
            National Taiwan University Hospital
          Aug 9, 2023

          Coronary Artery Disease Trial

          Not yet recruiting
          • Coronary Artery Disease
            • (no location specified)
            Jun 19, 2023

            Intracranial Atherosclerosis, Stroke Trial in Beijing (drug coated balloon, stent system)

            Recruiting
            • Intracranial Atherosclerosis
            • Stroke
            • drug coated balloon
            • stent system
            • Beijing, China
              Beijing Tiantan Hospital
            Aug 17, 2022

            Renal Transplantation Trial (TCD601, belatacept, ATG)

            Not yet recruiting
            • Renal Transplantation
            • TCD601
            • +5 more
            • (no location specified)
            Dec 20, 2022

            Coronary Artery Disease Trial in Washington (PCI with SELUTION SLR DCB, PCI with FDA approved "-limus" DES)

            Not yet recruiting
            • Coronary Artery Disease
            • PCI with SELUTION SLR DCB
            • PCI with FDA approved "-limus" DES
            • Washington, District of Columbia
              MedStar Washington Hospital Center
            Jul 7, 2023

            De Novo Lipogenesis (DNL) Trial in Basel (Assessment of de novo lipogenesis non-invasively in exhaled breath)

            Completed
            • De Novo Lipogenesis (DNL)
            • Assessment of de novo lipogenesis non-invasively in exhaled breath
            • Basel, Switzerland
              University Children's Hospital Basel (UKBB)
            Nov 3, 2022

            Breast Tumors, Treatment, Metastatic Breast Cancer Trial (surgical treatment 1, surgical treatment 2, Systemic therapy)

            Not yet recruiting
            • Breast Neoplasms
            • +3 more
            • surgical treatment 1
            • +2 more
            • (no location specified)
            Jul 17, 2022

            Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)

            Recruiting
            • Acute Myeloid Leukemia, Adult
            • cladribine + homoharringtonine + cytarabine
            • Hangzhou, Zhejiang, China
              The First Affiliated Hospital, Zhejiang University School of Med
            Jun 13, 2023

            Kidney Transplant; Complications, CMV Trial (Letermovir 480 mg once daily, Historical/Control)

            Not yet recruiting
            • Kidney Transplant; Complications
            • CMV
            • Letermovir 480 mg once daily
            • Historical/Control
            • (no location specified)
            Aug 14, 2023

            Kidney Transplant Rejection Trial (Enteric-Coated Mycophenolate Sodium (EC-MPS))

            Not yet recruiting
            • Kidney Transplant Rejection
            • Enteric-Coated Mycophenolate Sodium (EC-MPS)
            • (no location specified)
            May 23, 2023

            Peripheral Artery Disease (PAD) Trial (Stent PULSAR® -18 T3,)

            Not yet recruiting
            • Peripheral Artery Disease (PAD)
            • Stent PULSAR® -18 T3,
            • (no location specified)
            Dec 26, 2022

            Coronary Artery Disease Trial (DES, DCB)

            Not yet recruiting
            • Coronary Artery Disease
            • DES
            • DCB
            • (no location specified)
            Feb 20, 2023